INTERNATIONAL PATENT: TAVARGENIX GMBH FILES APPLICATION FOR "BENFO-OXYTHIAMINE (B-OT) AND/OR OXYTHIAMINE (OT) AS AN ACTIVE INGREDIENT OF A MEDICAMENT FOR THE TOPICAL TREATMENT OF VIRAL DISEASES OF THE SKIN"

GENEVA, Nov. 24 -- TAVARGENIX GMBH (GrafenhauserstraBe 2664293 Darmstadt) filed a patent application (PCT/DE2025/100446) for "BENFO-OXYTHIAMINE (B-OT) AND/OR OXYTHIAMINE (OT) AS AN ACTIVE INGREDIENT OF A MEDICAMENT FOR THE TOPICAL TREATMENT OF VIRAL DISEASES OF THE SKIN" on May 07, 2025. With publication no. WO/2025/237475, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): COY, Johannes F. (Dr.-Euteneuer-Str. 1363512 Hainburg)

Abstract: The invention relates to the substances benfo-oxythiamine and/or oxythiamine for use as...